Introduction Subjects & Methods

Results
Conclusions
Disclosure  This work was performed with the aid of the Investigation Committee on the Ossification of the Spinal Ligaments of the Japanese Ministry of Health, Labor, and Welfare.  None of the authors has any financial interest with any of the commercial entities.  All authors state that they have no conflicts of interest. 
Discussions
 Ossification of the Posterior Longitudinal Ligament of the spine (OPLL)
• OPLL is characterized by pathological ectopic ossification of the posterior longitudinal ligament ( Fig.1A-C ).
• OPLL induces compression myelopathy or radiculopathy by spinal stenosis, and the loss of spinal flexibility by ankylosing spinal hyperosteosis (ASH).
• Although the etiology of OPLL has not been fully elucidated, systemic and local bone formation factors may play an important role in its pathogenesis. Dickkopf-1(Dkk1) • The SOST gene encoding sclerostin is an osteocyte derived negative regulator of bone formation.
 Sclerostin &
• Sclerostin and Dkk-1 are the Wnt/β-catenin signal antagonists essential for bone formation. Piters E et al., Arch Biochemistry and Biophysics (2008) 473: 112-116. To compare serum sclerostin levels between OPLL patients and controls, and to identify the relationship between serum sclerostin level, Dkk-1 level, bone turnover markers, OPLL localization and numbers of ossified vertebra
Objectives Study Design : Cross-sectional study
Subjects:
Exception: 1) Non-ambulatory patient, 2) Person with kidney failure (≧ CKD stage 3) 3) Controls with OPLL confirmed by whole spine CT 
Patients demographics
Result.2
Serum sclerostin levels in OPLL male patients were significant higher than controls.
Result.3
The positive correlation between age and sclerostin levels was found in OPLL male patients. 
Male Female
(pmol/L) Control OPLL (r= 0.43, p=0.002) Result.4
In OPLL male patients, there were no relationships between serum sclerostin levels and bone turnover markers, and was a strong negative correlation between serum sclerostin and Dkk1 levels.
Result.5
In OPLL patients, there were no relationships between OPLL localization, numbers of ossified vertebra and ASH.  Systemic secretion of sclerostin by osteocytes increased in OPLL male patients with advancing age.
 There will be a negative feedback system by sclerostin to suppress development of OPLL and hyperosteosis in OPLL male patients.
 The negative effects on bone formation associated with higher serum sclerostin levels are counterbalanced by the underproduction of Dkk1 in OPLL male patients.
Negative feedback by sclerostin in OPLL male patients
Bone metabolism centering on sclerostin in controls
